Gold Corporate Council

Gold Corporate Council logo

The Gold Corporate Council was formed in 2017 to elevate humanism in healthcare and help advance the Gold Foundation’s mission.

The Gold Corporate Council represents some of the world’s foremost healthcare companies and a diversity of businesses within that industry. The five founding members are: BD (Becton, Dickinson and Company), Henry Schein, Inc., IBM Watson Health, Medtronic and Quest Diagnostics.

The Gold Corporate Council members have committed to adopting humanistic policies and procedures within their own organizations and to partnering with the Gold Foundation to impact change across the broader community. Council members will also facilitate expansion of humanism in healthcare deeper within their own organizations.

Read the announcement of the Gold Corporate Council’s formation and its aspiration statement.

About the Founding Members

ABOUT BD

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.

ABOUT HENRY SCHEIN, INC.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratoriesgovernment and institutional health care clinics, as well as other alternate care sites.Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries. The Company’s sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at: www.henryschein.comFacebook.com/HenrySchein and @HenrySchein on Twitter.

ABOUT IBM WATSON HEALTH

In April 2015, IBM launched the Watson Health business unit to help doctors, researchers, drug and device makers and other healthcare stakeholders accelerate innovation, deepen expertise and expand their knowledge base by surfacing insights from the massive amount of clinical, scientific, genetic and personal health data being created and shared daily.  The Watson Health portfolio offers a growing number of offerings across five key health market segments and is successfully working with businesses, health systems and governments worldwide to help solve pressing healthcare challenges and scale the use of cognitive computing technology across developing regions and mature markets. For more information on IBM Watson Health, visit: ibm.com/watsonhealth/.

ABOUT MEDTRONIC

Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

ABOUT QUEST DIAGNOSTICS

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. For more information, please visit www.QuestDiagnostics.com.

Read the full announcement of the Gold Corporate Council’s formation and its aspiration statement.